<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17	PATIENT COUNSELING INFORMATION<BR>               <BR>                  See FDA-approved patient labeling (Instructions for Use and Medication Guide).<BR>                  <BR>                     Advise patients that SYLATRON may be administered with antipyretics at bedtime to minimize common "flu-like" symptoms (including chills, fever, muscle aches, joint pain, headaches, tiredness).<BR>                     Advise patients to maintain hydration if experiencing "flu-like" symptoms.<BR>                     Advise patients and their caregivers to immediately report any symptoms of depression or suicidal ideation to their healthcare provider during treatment and up to 6 months after the last dose.<BR>                     Use SYLATRON during pregnancy only if the potential benefit justifies the potential risk to the fetus [see Use in Specific Populations (8.1)].<BR>                     Instruct patients to not re-use or share syringes and needles.<BR>                     Instruct patients on proper disposal of vials, syringes and needles.<BR>                  <BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>